Showing results (271-280 of 466) with videos related to

Sort By:
Pageof 47
REC, Interventional Cardiology|May 6, 2026
Drug-coated balloons vs drug-eluting stents for the treatment of large native coronary artery disease. Meta-analysis of randomized controlled trialsJosé Antonio Sorolla Romero, Laura Novelli, Jorge Llau García, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2021
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and StatinsMick P L Renkens, Gary S Mintz, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 20, 2022
The Clinical Profile and Natural History of Patients Who Fail Screening for Transcatheter Mitral Valve Replacement: Rationale and Design of the Prospective Multicenter Mitral Valve Screening Survey (MVSS)Giorgio A Medranda, Toby Rogers, Thomas Modine, et al.
The International Journal of Cardiovascular Imaging|January 29, 2015
Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine modelCarlos M Campos, Yuki Ishibashi, Jeroen Eggermont, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 14, 2017
The effect of coronary bifurcation and haemodynamics in prediction of atherosclerotic plaque development: a serial computed tomographic coronary angiographic studyAntonis Sakellarios, Christos V Bourantas, Stella-Lida Papadopoulou, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2015
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II studyLorenz Räber, Yoshinobu Onuma, Salvatore Brugaletta, et al.
Pageof 47